david geliebter

David Geliebter is a seasoned entrepreneur and executive with extensive leadership experience across multiple pharmaceutical companies. As Co-Founder and Executive Chairman of Learmont Pharmaceuticals and Woolsey Pharmaceuticals, Geliebter focuses on innovative treatments for rare cancers and neurodegenerative diseases, respectively. At Martin Pharmaceuticals, Geliebter aims to advance healthcare by repurposing existing drugs for rare medical conditions. Geliebter also co-founded Remedy Pharmaceuticals, dedicated to addressing central nervous system diseases, and Critical Diagnostics, which develops biomarkers for cardiovascular diseases. In addition to these ventures, Geliebter founded Embark Healthcare, emphasizing investment in the pharmaceutical industry, and has authored seven non-fiction books through Flat Squirrel Press. Prior experience includes founding and leading the Carson Group and Harvard Capital Group in the financial communications sector.